Clinical trial
Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced…
NCT00482807 · University of Nebraska, Other · Completed
Key facts
| NCT number | NCT00482807 |
|---|---|
| Title | Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer |
| Official title | Phase I Study Evaluating Extended Field Intensity Modulated Radiation Therapy and Docetaxel in Patients With Prostate Cancer Associated With Pelvic Node Metastasis |
| Lead sponsor | University of Nebraska, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | bicalutamide, docetaxel, goserelin, intensity-modulated radiation therapy |
| Enrollment | 9 |
| Start date | Aug 31, 2004 |
| Primary completion | Mar 9, 2010 |
| Completion | Mar 9, 2010 |
| First posted | Jun 5, 2007 |
| Last update posted | Nov 24, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: